ALR Industries LipoTherm — tested by NSF International (Ann Arbor, MI) and RIVM (Bilthoven, NL)

LipoTherm (ALR Industries), tested by NSF International (Ann Arbor, MI) and RIVM (Bilthoven, NL).
This is an independent test. Whoever paid for it had no interest in the answer.

Analyte	Found
deterenol	2.7 mg, per serving (1 caplet)
oxilofrine	21 mg, per serving (1 caplet)
phenpromethamine	3.1 mg, per serving (1 caplet)
BMPEA (beta-methylphenylethylamine)	5.7 mg, per serving (1 caplet)

Weight-loss caplet labelled as containing N-isopropylnorsynephrine HCl (a deterenol synonym). Cohen et al. 2021, Table 1: four prohibited stimulants — deterenol 2.7 ± 0.22, oxilofrine 21 ± 3.2, phenpromethamine 3.1 ± 0.40 and BMPEA 5.7 ± 0.25 mg per caplet; only deterenol was declared. Sample purchased online April 2018.

Source: Peer-reviewed analysis

Measured and reported inside a peer-reviewed paper, which names its methods and reports what it found including the negatives. Cite the paper, and read its own account of how the samples were obtained.

Report: doi.org

This entry records one test of one sample. It is not a statement about any other batch, and it is not a safety assessment.